熱門資訊> 正文
Travere Therapeutics申请混合货架产品
2024-08-02 05:47
- Travere Therapeutics (NASDAQ:TVTX) on Thursday said that it filed a prospectus for a mixed shelf offering, with the size undisclosed.
- The prospectus is not an offer to sell.
- SEC Filing.
More on Travere Therapeutics
- Travere Therapeutics, Inc. (TVTX) Q1 2024 Earnings Call Transcript
- Travere Therapeutics Q2 2024 Earnings Preview
- Travere gains on Novartis data for Filspari rival, Calliditas buyout
- Seeking Alpha’s Quant Rating on Travere Therapeutics
- Historical earnings data for Travere Therapeutics
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。